Caribou Biosciences, Inc. (CRBU) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 148.49M |
| Enterprise Value | 163.36M |
| P/E Ratio | -1.15 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 14.52 |
| Price/Book Ratio | 1.54 |
| Enterprise/Revenue | 15.85 |
| Enterprise/EBITDA | -1.59 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -11.89 |
| Operating Margin | -11.76 |
AD
Management Effectiveness
| Return On Assets | -0.89 |
| Return On Equity | -1 |
Income Statement
| Revenue | 11.16M |
| Revenue/Share | 0.12 |
| Gross Profit | 7.51M |
| EBITDA | -145.03M |
| Net Income | -148.13M |
| Diluted EPS | -1.59 |
Balance Sheet
| Total Cash | 117.63M |
| Total Cash/Share | 1.23 |
| Total Debt | 26.95M |
| Total Debt/Equity | 0.26 |
| Current Ratio | 6.22 |
| Book Value Per Share | 1.06 |
Price History
| 52-Week Change | 24.24 |
| 52-Week High | 3.54 |
| 52-Week Low | 1.2 |
| Moving Average 50 Days | 2.02 |
| Moving Average 200 Days | 1.94 |
Statistics
| Average Volume | 1.6M |
| Shares Outstanding | 99.18M |
| % Held by Institutions | 40.52 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
